Stanley Cohan - Publications, H-index & Citations

Stanley Cohan

Biogen

28H指数

151论文数

5.5K被引数

收录论文 25

发表时间

Safety and tolerability of conversion to siponimod from other disease-modifying therapies in patients with advancing forms of relapsing MS: Results from the EXCHANGE study 从其他疾病修正疗法转换为西尼莫德在进展型复发缓解型多发性硬化患者中的安全性与耐受性：EXCHANGE研究的结果

MULTIPLE SCLEROSIS JOURNAL

IF5

2025-04-18

PREAI

Fox, Robert J.; Cohan, Stanley; Mao-Draayer, Yang; Weinstock-Guttman, Bianca; Cruz, Linda-Ali; Arnould, Sophie; Cox, Gina Mavrikis; Bar-Or, Amit

Cognitive effects of ocrelizumab vs interferon β-1a in relapsing multiple sclerosis: A post hoc analysis of the OPERA I/II trials 奥法木单抗与干扰素β-1a在复发型多发性硬化中的认知效应比较：OPERA I/II试验的事后分析

MULTIPLE SCLEROSIS AND RELATED DISORDERS

IF2.9

2025-03-01

PREAI

Benedict, Ralph H. B.; Kappos, Ludwig; Miller, Aaron; Hartung, Hans-Peter; Overell, James; Pei, Jinglan; Dahlke, Frank; Bernasconi, Corrado; Koendgen, Harold; Wang, Qing; Bonati, Ulrike; Cohan, Stanley

Multi-Omic characterization of the effects of Ocrelizumab in patients with relapsing-remitting multiple sclerosis

JOURNAL OF THE NEUROLOGICAL SCIENCES

IF3.2

2024-12-01

PREAI

Kornilov, Sergey A.; Price, Nathan D.; Gelinas, Richard; Acosta, Juan; Brunkow, Mary E.; Gervasi-Follmar, Tiffany; Winger, Ryan C.; Aldershoff, Dmitri; Lausted, Christopher; Troisch, Pamela; Smith, Brett; Heath, James R.; Repovic, Pavle; Cohan, Stanley; Magis, Andrew T.

Efficacy of Ofatumumab and Teriflunomide in Patients With Relapsing MS From Racial/Ethnic Minority Groups ASCLEPIOS I/II Subgroup Analyses

NEUROLOGY

IF8.5

2024-08-13

OAAI

Williams, Mitzi J.; Amezcua, Lilyana; Cohan, Stanley L.; Cohen, Jeffrey A.; Delgado, Silvia R.; Hua, Le H.; Lucassen, Elisabeth B.; Piccolo, Rebecca S.; Koulouris, Chloe R.; Stankiewicz, James

Development and validation of a claims-based algorithm to identify patients with Neuromyelitis Optica Spectrum disorder

JOURNAL OF THE NEUROLOGICAL SCIENCES

IF3.2

2024-08-01

PREAI

Patel, Anisha M.; Exuzides, Alex; Yermilov, Irina; Dalglish, Hannah; Gibbs, Sarah N.; Reddy, Sheila R.; Chang, Eunice; Paydar, Caleb; Broder, Michael S.; Cohan, Stanley; Greenberg, Benjamin; Levy, Michael

Real-World Safety and Effectiveness After 5 Years of Dimethyl Fumarate Treatment in Black and Hispanic Patients with Multiple Sclerosis in ESTEEM

NEUROLOGY AND THERAPY

IF4.8

2023-06-24

OAAI

Williams, Mitzi J.; Amezcua, Lilyana; Chinea, Angel; Cohan, Stanley; Okai, Annette; Okuda, Darin T.; Vargas, Wendy; Belviso, Nick; Bozin, Ivan; Jiang, Xiaotong; Lewin, James B.; Lyons, Jennifer; Shen, Changyu; England, Sarah M.; Grimes, Nydjie

Evaluating the efficacy and safety of transitioning patients with multiple sclerosis from natalizumab to ocrelizumab (OCTAVE)

MULTIPLE SCLEROSIS JOURNAL

IF5

2023-06-15

PREAI

Smoot, Kyle; Marginean, Horia; Gervasi-Follmar, Tiffany; Chen, Chiayi; Repovic, Pavle; Cohan, Stanley

The Two Sides of Siponimod: Evidence for Brain and Immune Mechanisms in Multiple Sclerosis

CNS DRUGS

IF7.4

2022-06-20

OAAI

Cohan, Stanley L.; Benedict, Ralph H. B.; Cree, Bruce A. C.; DeLuca, John; Hua, Le H.; Chun, Jerold

Interferons and Multiple Sclerosis: Lessons from 25 Years of Clinical and Real-World Experience with Intramuscular Interferon Beta-1a (Avonex)干扰素和多发性硬化症: 肌肉内干扰素Beta-1a (Avonex) 25年临床和现实经验的教训

CNS DRUGS

IF7.4

2021-07-06

OAAI

Cohan, Stanley L.; Hendin, Barry A.; Reder, Anthony T.; Smoot, Kyle; Avila, Robin; Mendoza, Jason P.; Weinstock-Guttman, Bianca

Comparative Efficacy and Safety of Ozanimod and Dimethyl Fumarate for Relapsing-Remitting Multiple Sclerosis Using Matching-Adjusted Indirect Comparison

CNS DRUGS

IF7.4

2021-04-13

OAAI

Cohan, Stanley; Kumar, Jinender; Arndorfer, Stella; Zhu, Xuelian; Zivkovic, Marko; Tencer, Tom

Effectiveness of Dimethyl Fumarate in Patients With Relapsing Multiple Sclerosis Switching After Suboptimal Response to Glatiramer Acetate, Including Patients With Early Multiple Sclerosis: Subgroup Analysis of RESPOND

NEUROLOGY AND THERAPY

IF4.8

2020-11-23

OAAI

Repovic, Pavle; Robertson, Derrick; Kresa-Reahl, Kiren; Cohan, Stanley L.; Su, Ray; Avila, Robin; Koulinska, Irene; Mendoza, Jason P.

Evaluating the Utility of Smartphone-Based Sensor Assessments in Persons With Multiple Sclerosis in the Real-World Using an App (elevateMS): Observational, Prospective Pilot Digital Health Study

JMIR MHEALTH AND UHEALTH

IF6.2

2020-10-27

OAAI

Pratap, Abhishek; Grant, Daniel; Vegesna, Ashok; Tummalacherla, Meghasyam; Cohan, Stanley; Deshpande, Chinmay; Mangravite, Lara; Omberg, Larsson

Sphingosine-1-Phosphate: Its Pharmacological Regulation and the Treatment of Multiple Sclerosis: A Review Article

BIOMEDICINES

IF3.9

2020-07-18

OAAI

Cohan, Stanley; Lucassen, Elisabeth; Smoot, Kyle; Brink, Justine; Chen, Chiayi

Real-World Safety and Effectiveness of Dimethyl Fumarate in Black or African American Patients with Multiple Sclerosis: 3-Year Results from ESTEEM

NEUROLOGY AND THERAPY

IF4.8

2020-05-29

OAAI

Williams, Mitzi J.; Amezcua, Lilyana; Okai, Annette; Okuda, Darin T.; Cohan, Stanley; Su, Ray; Parks, Becky; Mendoza, Jason P.; Lewin, James B.; Jones, Cynthia C.

Daclizumab: Mechanisms of Action, Therapeutic Efficacy, Adverse Events and Its Uncovering the Potential Role of Innate Immune System Recruitment as a Treatment Strategy for Relapsing Multiple Sclerosis

BIOMEDICINES

IF3.9

2019-03-11

OAAI

Cohan, Stanley L.; Lucassen, Elisabeth B.; Romba, Meghan C.; Linch, Stefanie N.

Real-World Characterization of Dimethyl Fumarate-Related Gastrointestinal Events in Multiple Sclerosis: Management Strategies to Improve Persistence on Treatment and Patient Outcomes

NEUROLOGY AND THERAPY

IF4.8

2019-01-31

OAAI

Min, Jinny; Cohan, Stanley; Alvarez, Enrique; Sloane, Jacob; Phillips, J. Theodore; van der Walt, Anneke; Koulinska, Irene; Fang, Fang; Miller, Catherine; Chan, Andrew

Outcomes of Stable Multiple Sclerosis Patients Staying on Initial Interferon Beta Therapy Versus Switching to Another Interferon Beta Therapy: A US Claims Database Study

ADVANCES IN THERAPY

IF4

2018-10-20

OAAI

Cohan, Stanley; Smoot, Kyle; Kresa-Reahl, Kiren; Garland, Robert; Yeh, Wei-Shi; Wu, Ning; Watson, Crystal

Efficacy of daclizumab beta versus intramuscular interferon beta-1a on disability progression across patient demographic and disease activity subgroups in DECIDE Dife中daclizumab β 与肌内干扰素beta-1a对患者人口统计学和疾病活动亚组的残疾进展的疗效

MULTIPLE SCLEROSIS JOURNAL

IF5

2017-10-06

OAAI

Cohan, Stanley; Kappos, Ludwig; Giovannoni, Gavin; Wiendl, Heinz; Selmaj, Krzysztof; Havrdova, Eva Kubala; Rose, John; Greenberg, Steven; Phillips, Glenn; Ma, Wei; Wang, Ping; Lima, Gabriel; Sabatella, Guido

Three-year clinical outcomes of relapsing multiple sclerosis patients treated with dimethyl fumarate in a United States community health center

MULTIPLE SCLEROSIS JOURNAL

IF5

2017-05-24

PREAI

Smoot, Kyle; Spinelli, Kateri J.; Stuchiner, Tamela; Lucas, Lindsay; Chen, Chiayi; Grote, Lois; Baraban, Elizabeth; Kresa-Reahl, Kiren; Cohan, Stanley

Improved cognitive outcomes in patients with relapsing-remitting multiple sclerosis treated with daclizumab beta: Results from the DECIDE study

MULTIPLE SCLEROSIS JOURNAL

IF5

2017-05-09

OAAI

Benedict, Ralph H. B.; Cohan, Stanley; Lynch, Sharon G.; Riester, Katherine; Wang, Ping; Castro-Borrero, Wanda; Elkins, Jacob; Sabatella, Guido

研究方向